ConductScience.org, home

Comparison · NCT02130986-deaths

Procalcitonin (PCT) Group vs Usual Care Group: deaths from any cause

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Procalcitonin (PCT) Group vs Usual Care Group: deaths from any cause. Trial comparisons, record NCT02130986-deaths. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02130986-deaths

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.01940.0120.0312wilson
Risk in group 20.0120.006560.022wilson
Risk difference, group 1 minus group 20.00732-0.005110.0204newcombe hybrid score
Risk ratio, group 1 over group 21.610.7343.52log
Odds ratio, group 1 over group 21.620.7313.59log
Number needed to harm, for one more death from any cause on Procalcitonin (PCT) Group than on Usual Care Group137from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: usual care.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Procalcitonin (PCT) Group
Procalcitonin (PCT)~Results of procalcitonin level provided to treating clinician (initial in the ED, 6-24 hrs after initial. and Day 3, 5, 7 if in hospital AND on abx or at the treating clinician's discretion)~Telephone Visit at Day 15 and Day 30 to collect ABX days, post-d/c resource use and AQ-20 questionnaire~Bio-bank samples collected in ED for storage at Coordinating Center
16826EG000
Group 2Usual Care GroupUsual Care~Telephone Visit at Day 15 and Day 30 to collect ABX days, post-d/c resource use and AQ-20 questionnaire~Bio-bank samples collected in ED for storage at Coordinating Center10830EG001

Harm

What it counts
Total, all-cause mortality
Time frame
By day 30.

Source ClinicalTrials.gov

Trial

Title
Procalcitonin Antibiotic Consensus Trial (ProACT)
NCT number
NCT02130986
Phases
NA
Conditions
Lower Respiratory Tract Infection (LRTI)
Interventions
Procalcitonin level, Results of procalcitonin (PCT) level to treating clinician, Provide procalcitonin guideline to treating clinician, Telephone Visit
Lead sponsor
University of Pittsburgh
Results first posted
2019-01-15

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02130986-deaths